Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
58.52
-0.77 (-1.30%)
Sep 29, 2025, 2:45 PM CST
SHE:300347 Revenue
Hangzhou Tigermed Consulting had revenue of 1.69B CNY in the quarter ending June 30, 2025, a decrease of -0.69%. This brings the company's revenue in the last twelve months to 6.50B, down -7.62% year-over-year. In the year 2024, Hangzhou Tigermed Consulting had annual revenue of 6.60B, down -10.58%.
Revenue (ttm)
6.50B
Revenue Growth
-7.62%
P/S Ratio
7.46
Revenue / Employee
633.63K
Employees
10,185
Market Cap
48.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.60B | -780.92M | -10.58% |
Dec 31, 2023 | 7.38B | 298.57M | 4.21% |
Jan 1, 2023 | 7.09B | 1.87B | 35.91% |
Jan 1, 2022 | 5.21B | 2.02B | 63.32% |
Dec 31, 2020 | 3.19B | 388.97M | 13.88% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Shanghai United Imaging Healthcare | 10.98B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |
Hangzhou Tigermed Consulting News
- 1 year ago - Hangzhou Tigermed Consulting reports Q2 results - Seeking Alpha